IMROVYO
Dead / Abandoned — Abandoned — no statement of use filed (as of 06 Oct 2025)
What this means for you
This application is over — abandoned 06 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97920248
- Mark type
- Stylized text
- Filed
- 04 May 2023
- Published for opposition
- 09 Jul 2024
- Abandoned
- 06 Oct 2025
- Attorney of record
- Danny M. Awdeh
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related diseases; pharmaceutical preparations for the treatment of acromegaly, carcinoid syndrome, neuroendocrine tumors, and cancer; all for human use
Owner
- Crinetics Pharmaceuticals, Inc., San Diego, CA, US
- Crinetics Pharmaceuticals, Inc., San Diego, CA, US
Prosecution history
- 06 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 06 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Dec 2024 — SOU EXTENSION 1 GRANTED
- 05 Dec 2024 — SOU EXTENSION 1 FILED
- 05 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 03 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jul 2024 — PUBLISHED FOR OPPOSITION
- 19 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 May 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 May 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 May 2024 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 05 Apr 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED